'It raises hope': A new drug for schizophrenia approved for the first time in 70 years
The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...
Sydney Morning Herald10h
The Australian research (and brains) that led to a new schizophrenia drug
US researchers at pharmaceutical company Eli Lilly were investigating the drug xanomeline – which activates muscarinic ...
BioSpace14h
The Making of BMS’ Cobenfy: From Alzheimer’s to Schizophrenia
From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...
AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team
AstronauTx Ltd ('AstronauTx'), a biotechnology company developing novel treatments for Alzheimer's disease and other ...